产品编号：B675700
产品规格：10mg
产品价格：面议
| 标准品编号: | B675700 |
| 名称: | Bortezomib |
| 别名: | B-[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid; [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid; Velcade; Radiciol; NSC 681239; DPBA; LDP 341; MG 341; MLN 341; NSC 681239; PS 314; PS 341; Radiciol; Velcade; |
| CAS号: | 179324-69-7 |
| 分子式: | C₁₉H₂₅BN₄O₄ |
| 外观: | 白色至白色固体 |
| 熔点: | >120°C (dec.) |
| 分子量: | 384.24 |
| 储存: | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
| 溶解度: | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
| 稳定性: | Hygroscopic and Moisture Sensitive |
| 类别: | Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| Boiling Point: | N/A |
| 应用: | Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. |
| 危险品信息: | Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package |
| 参考文献 | |
